Studies have shown that golgi vesicle transporter 1A (GOLT1A) (17, 18), another member of golgi vesicle transporter family, affects tamoxifen sensitivity in breast cancer and promotes cell proliferation in lung cancer. This evidence concerns the gene GOLT1A and breast carcinoma.